[The use of low-frequency ultrasound in the combined therapy of pulmonary tuberculosis patients].
The validity of low-frequency ultrasound (LFU) addition to specific therapy of pulmonary tuberculosis (PT) was investigated in 2 groups of PT new cases. The study group (n = 25) received specific therapy and ultrasonic treatment (44 KHz, amplitude 2 microm to the paravertebral region and PT zones). The control group (n = 25) received specific therapy only. The response to treatment was higher in the study group. The findings support validity of low-frequency ultrasound use as an adjuvant in treatment of PT new cases.